Back
Trevi Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Buy
63
TRVI
Trevi Therapeutics
Last Price:
2.54
Seasonality Move:
30.11%
Buy
51
NBY
NovaBay Pharmaceuticals
Last Price:
0.16
Seasonality Move:
2.11%
Buy
63
Trevi Therapeutics (TRVI)
is a Buy
Is Trevi Therapeutics a Buy, Sell or Hold?
- The current Trevi Therapeutics [TRVI] share price is $2.56. The Score for TRVI is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- TRVI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
51
NovaBay Pharmaceuticals (NBY)
is a Buy
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.14. The Score for NBY is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- NBY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
TRVI Stock Price Chart
What is Trevi Therapeutics's stock price today?
-
The Trevi Therapeutics share price today is $2.56
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TRVI is experiencing buying pressure, which is a positive indicator for future bullish movement.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.14
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBY is experiencing slight buying pressure.
TRVI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 42.24 | Sell |
| Chaikin Money Flow: | 104848 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.63 - 2.93) | Sell |
| Bollinger Bands (100): | (1.79 - 3.21) | Buy |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 60.93 | Buy |
| Chaikin Money Flow: | 1917543 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.07 - 0.13) | Buy |
| Bollinger Bands (100): | (0.1 - 0.16) | Buy |
TRVI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.68 | Sell |
| 20-day SMA: | 2.79 | Sell |
| 50-day SMA: | 2.96 | Sell |
| 200-day SMA: | 2.13 | Buy |
| 8-day EMA: | 2.64 | Sell |
| 20-day EMA: | 2.74 | Sell |
| 50-day EMA: | 2.76 | Sell |
| 200-day EMA: | 2.36 | Buy |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.14 | Buy |
| 20-day SMA: | 0.11 | Buy |
| 50-day SMA: | 0.1 | Buy |
| 200-day SMA: | 0.27 | Sell |
| 8-day EMA: | 0.13 | Buy |
| 20-day EMA: | 0.12 | Buy |
| 50-day EMA: | 0.11 | Buy |
| 200-day EMA: | 0.48 | Sell |
Trevi Therapeutics Earnings Growth & TRVI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.12 per share, and a decrease next year of $0.08 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.35 per share, an increase next quarter of $0.06 per share, an increase this year of $2.04 per share, and an increase next year of $0.30 per share.
Trevi Therapeutics Technical Analysis
| May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 14 | 15 | 16 | 17 | 20 | 21 | 22 | 23 | 24 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals Technical Analysis
| May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 14 | 15 | 16 | 17 | 20 | 21 | 22 | 23 | 24 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||